Cilostazol attenuates kainic acid-induced hippocampal cell death

Cilostazol is a selective inhibitor of type 3 phosphodiesterase (PDE3) and has been widely used as an antiplatelet agent. Cilostazol mediates this activity through effects on the cyclic adenosine monophosphate (cAMP) signaling cascade. Recently, it has attracted attention as a neuroprotective agent....

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Young-Seop, Jin, Zhen, Jeong, Eun Ae, Yi, Chin-ok, Lee, Jong Youl, Park, In Sung, Roh, Gu Seob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746513/
https://www.ncbi.nlm.nih.gov/pubmed/29302213
http://dx.doi.org/10.4196/kjpp.2018.22.1.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746513/
https://www.ncbi.nlm.nih.gov/pubmed/29302213
http://dx.doi.org/10.4196/kjpp.2018.22.1.63

Ejemplares similares